IFNA1 and COVID-19: Similar to SARS-CoV (21), critical SARS-CoV-2 infection dampens the antiviral type 1 interferon (IFN) response detectable in peripheral blood (10) despite the presence of an inflammatory blood monocyte population with yet a strong IFN stimulated gene (ISG) signature in mild COVID-19 (22).